CompanyDrug

Pfizer and CStone Secure NMPA Approval for Sugemalimab, First PD-L1 Inhibitor for ESCC

Company

Sanofi Eyes Blockbuster Potential with 12 Pipeline Assets, Projects EUR 10 Billion in Annual Sales by 2030

CompanyDeals

AbelZeta and AstraZeneca Team Up for Co-Development of GPC3-Targeted CAR-T Therapy

CompanyDeals

Shanghai Henlius Partners with China Resource Medicine to Enhance Product Accessibility

CompanyDeals

Medtronic Exits $738 Million Deal to Acquire EOFlow Amid Regulatory and Legal Challenges

CompanyMedical Device

AK Medical Secures NMPA Approval for Advanced 3D-Printed Hip Prosthesis Component

CompanyDrug

Bio-Thera Secures FDA Approval for Avzivi, a Biosimilar to Roche’s Avastin

CompanyDrug

Mabwell Secures NMPA Approval for Phase III Study of ADC 9MW2821 in Urothelial Carcinoma

CompanyDrug

HutchMed’s Sovleplenib Set for Priority Review in China for Chronic Immune Thrombocytopenia

CompanyDrug

Trinomab’s TNM002 Antitetanus Monoclonal Antibody Filing Accepted for Review in China

CompanyDeals

BMS Broadens Scope of IMID Collaboration, Aiming for Deeper Insights into Sjögren’s and Atopic Dermatitis

CompanyDrug

Eli Lilly Seeks Approval for Pirtobrutinib in China for Relapsed Mantle Cell Lymphoma